Kyung Nam Pharm Co.,Ltd. (KOSDAQ:053950)

Kyung Nam Pharm Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 28, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	48,920	62,596	59,868	82,676	88,518	140,585
Market Cap Growth	0.41%	4.56%	-27.59%	-6.60%	-37.04%	-17.15%
Enterprise Value	40,215	69,553	82,641	73,133	109,068	157,440
Last Close Price	626.00	801.00	1345.73	2144.21	3122.28	5700.02
PE Ratio	5.09	6.21	-	-	-	-
PS Ratio	0.87	1.03	1.01	1.40	1.37	1.98
PB Ratio	0.43	0.54	0.67	0.88	1.22	2.45
P/TBV Ratio	0.43	0.55	0.86	0.89	1.24	2.48
P/OCF Ratio	81.41	34.05	86.35	1155.05	-	53.76
EV/Sales Ratio	0.72	1.14	1.39	1.24	1.69	2.22
EV/EBITDA Ratio	14.77	31.16	-	-	-	38.38
EV/EBIT Ratio	60.46	-	-	-	-	61.11
EV/FCF Ratio	-6.13	-	-	-	-	-
Debt / Equity Ratio	0.32	0.33	0.57	0.35	0.55	0.72
Debt / EBITDA Ratio	13.37	16.84	-	-	-	10.09
Asset Turnover	0.35	0.37	0.39	0.45	0.51	0.71
Inventory Turnover	3.11	3.39	3.07	3.21	3.69	4.39
Quick Ratio	1.43	1.41	0.81	1.35	1.56	1.22
Current Ratio	1.76	1.68	1.03	1.70	2.16	1.49
Return on Equity (ROE)	-3.29%	-3.98%	-10.42%	-9.41%	-4.94%	-8.66%
Return on Assets (ROA)	0.24%	-0.09%	-1.47%	-1.62%	-4.34%	1.60%
Return on Capital (ROIC)	0.27%	-0.10%	-1.68%	-1.78%	-5.19%	2.00%
Return on Capital Employed (ROCE)	0.50%	-	-	-	-	2.90%
Earnings Yield	19.64%	16.10%	-35.07%	-9.47%	-3.86%	-3.90%
FCF Yield	-13.42%	-7.43%	-26.94%	-3.36%	-13.16%	-30.56%
Buyback Yield / Dilution	-52.38%	-22.60%	-21.50%	-27.71%	-32.46%	-11.06%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.